Oaktree Acquisition today filed an amended proxy outlining newly registered shares in connection with the SPAC’s pending merger with Hims & Hers, a telemedicine company.
The combined company is expected to have an implied initial enterprise value of approximately $1.6 billion, and an estimated $330 million in cash after closing.
A shareholder vote is expected by year’s end, although the amended proxy does not cite a specific date. Read more.
